SEBI: Exonerates Piramal Pharma for LODR violations, absent “materiality criteria” impacting market perception

Nov 11, 2024
|

Simply Register/Sign In to access the free content across the portals!

Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals

View Subscriptions

Sign in to access the content